☰

Yujie Tang - Publications

Affiliations: 
Shanghai Jiao Tong University School of Medicine 
Tree Info Grants Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Sui Y, Wang T, Mei Y, Zhu Y, Jiang W, Shen J, Yan S, Lu W, Zhao K, Mo J, Wang C, Tang Y. Targeting Super-Enhancer-Driven Transcriptional Dependencies Suppresses Aberrant Hedgehog Pathway Activation and Overcomes Smoothened Inhibitor Resistance. Cancer Research. PMID 38775809 DOI: 10.1158/0008-5472.CAN-23-3306  0.344
2022 Mo J, Tan K, Dong Y, Lu W, Liu F, Mei Y, Huang H, Zhao K, Lv Z, Ye Y, Tang Y. Therapeutic targeting the oncogenic driver EWSR1::FLI1 in Ewing sarcoma through inhibition of the FACT complex. Oncogene. PMID 36357572 DOI: 10.1038/s41388-022-02533-1  0.34
2021 Mo J, Liu F, Sun X, Huang H, Tan K, Zhao X, Li R, Jiang W, Sui Y, Chen X, Shen K, Zhang L, Ma J, Zhao K, Tang Y. Inhibition of the FACT complex targets aberrant hedgehog signaling and overcomes resistance to smoothened antagonists. Cancer Research. PMID 33853831 DOI: 10.1158/0008-5472.CAN-20-3186  0.35
2021 Ehteda A, Simon S, Franshaw L, Giorgi FM, Liu J, Joshi S, Rouaen JRC, Pang CNI, Pandher R, Mayoh C, Tang Y, Khan A, Ung C, Tolhurst O, Kankean A, et al. Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG. Cell Reports. 35: 108994. PMID 33852836 DOI: 10.1016/j.celrep.2021.108994  0.335
2020 Wang J, Sui Y, Li Q, Zhao Y, Dong X, Yang J, Liang Z, Han Y, Tang Y, Ma J. Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137. Cell Death & Disease. 11: 1029. PMID 33268769 DOI: 10.1038/s41419-020-03201-6  0.3
2019 Liu F, Jiang W, Sui Y, Meng W, Hou L, Li T, Li M, Zhang L, Mo J, Wang J, Zhao Y, Zhang L, Ma J, Tang Y. CDK7 inhibition suppresses aberrant hedgehog pathway and overcomes resistance to smoothened antagonists. Proceedings of the National Academy of Sciences of the United States of America. PMID 31182587 DOI: 10.1073/Pnas.1815780116  0.429
2019 Lu P, Geng J, Zhang L, Wang Y, Niu N, Fang Y, Liu F, Shi J, Zhang ZG, Sun YW, Wang LW, Tang Y, Xue J. THZ1 reveals CDK7-dependent transcriptional addictions in pancreatic cancer. Oncogene. PMID 30692639 DOI: 10.1038/S41388-019-0701-1  0.444
2019 Zhang L, Li M, Hou L, Zhang L, Tang Y. MEDU-06. TARGETING MYC AND OTX2-DRIVEN TRANSCRIPTIONAL DEPENDENCIES OF GROUP 3 MEDULLOBLASTOMA THROUGH CDK7 INHIBITION Neuro-Oncology. 21: ii104-ii104. DOI: 10.1093/Neuonc/Noz036.166  0.37
2018 Meng W, Wang J, Wang B, Liu F, Li M, Zhao Y, Zhang C, Li Q, Chen J, Zhang L, Tang Y, Ma J. CDK7 inhibition is a novel therapeutic strategy against GBM both in vitro and in vivo. Cancer Management and Research. 10: 5747-5758. PMID 30532595 DOI: 10.2147/CMAR.S183696  0.306
2018 Liu X, Bao Y, Meng W, Yang P, An Y, Ma J, Tang Y, Liu Z, Lu Y, Zhou J, Zhang Y, Feng J, Gao X, Su Z, Pu Y, et al. TROY interacts with RKIP to promote glioma development. Oncogene. PMID 30337686 DOI: 10.1038/S41388-018-0503-X  0.384
2018 Meng W, Wang B, Mao W, Wang J, Zhao Y, Li Q, Zhang C, Tang Y, Ma J. Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma. Journal of Experimental & Clinical Cancer Research : Cr. 37: 241. PMID 30285808 DOI: 10.1186/S13046-018-0916-Y  0.398
2018 Meng W, Wang J, Li Q, Liu F, Li M, Jiang W, Lin L, Dai X, Wang H, Zhang C, Wang B, Chen J, Zhang L, Tang Y, Ma J. TBIO-01. TARGETING TRANSCRIPTIONAL ADDICTION FOR GBM THERAPY THROUGH CDK7 INHIBITION Neuro-Oncology. 20: i180-i180. DOI: 10.1093/Neuonc/Noy059.690  0.351
2018 Li M, Wang J, Sui Y, Li T, Liu F, Zhang L, Jiang W, Ma J, Monje M, Tang Y. DIPG-41. IDENTIFICATION OF BIRC5 AS A NOVEL THERAPEUTIC TARGET FOR DIFFUSE INTRINSIC PONTINE GLIOMA Neuro-Oncology. 20: i57-i57. DOI: 10.1093/Neuonc/Noy059.134  0.655
2017 Nagaraja S, Vitanza NA, Woo PJ, Taylor KR, Liu F, Zhang L, Li M, Meng W, Ponnuswami A, Sun W, Ma J, Hulleman E, Swigut T, Wysocka J, Tang Y, et al. Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma. Cancer Cell. PMID 28434841 DOI: 10.1016/J.Ccell.2017.03.011  0.745
2017 Nagaraja S, Vitanza N, Woo P, Taylor K, Liu F, Zhang L, Li M, Meng W, Ponnuswami A, Sun W, Ma J, Hulleman E, Swigut T, Wysocka J, Tang Y, et al. PDTM-29. TRANSCRIPTIONAL DEPENDENCIES IN DIFFUSE INTRINSIC PONTINE GLIOMA Neuro-Oncology. 19: vi196-vi196. DOI: 10.1093/Neuonc/Nox168.793  0.668
2017 Zhang L, Li M, Sui Y, Liu F, Jiang W, Li T, Tang Y. PDTM-16. IDENTIFICATION OF NOVEL EPIGENETIC DRUG COMBINATIONS WITH SYNERGISTIC INHIBITORY EFFECTS AGAINST MYC-AMPLIFIED GROUP 3 MEDULLOBLASTOMA Neuro-Oncology. 19: vi193-vi193. DOI: 10.1093/Neuonc/Nox168.780  0.3
2017 Liu F, Li M, Zhang L, Sui Y, Jiang W, Meng W, Wang J, Ma J, Tang Y. ATRT-06. BET INHIBITORS AND HDAC INHIBITORS WORK SYNERGISTICALLY IN TREATING MULTIPLE SUBTYPES OF ATYPICAL TERATOID/RHABDOID TUMOR Neuro-Oncology. 19: iv2-iv2. DOI: 10.1093/Neuonc/Nox083.005  0.354
2016 Jones C, Karajannis MA, Jones DT, Kieran MW, Monje M, Baker SJ, Becher OJ, Cho YJ, Gupta N, Hawkins C, Hargrave D, Haas-Kogan DA, Jabado N, Li XN, Mueller S, ... ... Tang Y, et al. Pediatric high-grade glioma: biologically and clinically in need of new thinking. Neuro-Oncology. PMID 27282398 DOI: 10.1093/Neuonc/Now101  0.557
2016 Tang Y, Nagaraja S, Vitanza NA, Woo P, Ponnuswami A, Monje M. HG-23BET INHIBITORS WORK SYNERGISTICALLY WITH PANOBINOSTAT IN TREATING DIFFUSE INTRINSIC PONTINE GLIOMA Neuro-Oncology. 18: iii52.3-iii52. DOI: 10.1093/Neuonc/Now073.20  0.718
2016 Vitanza N, Nagaraja S, Woo P, Tang Y, Monje M. HG-16CDK7 INHIBITION IN DIFFUSE INTRINSIC PONTINE GLIOMA Neuro-Oncology. 18: iii51.1-iii51. DOI: 10.1093/Neuonc/Now073.14  0.725
2015 Grasso CS, Tang Y, Truffaux N, Berlow NE, Liu L, Debily MA, Quist MJ, Davis LE, Huang EC, Woo PJ, Ponnuswami A, Chen S, Johung TB, Sun W, Kogiso M, et al. Erratum: Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nature Medicine. 21: 827. PMID 26151328 DOI: 10.1038/Nm0715-827A  0.75
2015 Grasso CS, Tang Y, Truffaux N, Berlow NE, Liu L, Debily MA, Quist MJ, Davis LE, Huang EC, Woo PJ, Ponnuswami A, Chen S, Johung TB, Sun W, Kogiso M, et al. Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nature Medicine. 21: 555-9. PMID 25939062 DOI: 10.1038/Nm.3855  0.765
2015 Venkatesh HS, Johung TB, Caretti V, Noll A, Tang Y, Nagaraja S, Gibson EM, Mount CW, Polepalli J, Mitra SS, Woo PJ, Malenka RC, Vogel H, Bredel M, Mallick P, et al. Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion. Cell. 161: 803-16. PMID 25913192 DOI: 10.1016/J.Cell.2015.04.012  0.587
2015 Grasso CS, Tang Y, Truffaux N, Berlow NE, Liu L, Debily M, Quist MJ, Davis L, Huang EC, Woo PJ, Ponnuswami A, Chen S, Johung T, Sun W, Kogiso M, et al. BT-02 * FUNCTIONALLY-DEFINED THERAPEUTIC TARGETS IN DIFFUSE INTRINSIC PONTINE GLIOMA Neuro-Oncology. 17: iii3-iii3. DOI: 10.1093/Neuonc/Nov061.12  0.766
2014 Tang Y, Gholamin S, Schubert S, Willardson MI, Lee A, Bandopadhayay P, Bergthold G, Masoud S, Nguyen B, Vue N, Balansay B, Yu F, Oh S, Woo P, Chen S, et al. Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition. Nature Medicine. 20: 732-40. PMID 24973920 DOI: 10.1038/Nm.3613  0.618
2014 Lober RM, Cho YJ, Tang Y, Barnes PD, Edwards MS, Vogel H, Fisher PG, Monje M, Yeom KW. Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma. Journal of Neuro-Oncology. 117: 175-82. PMID 24522717 DOI: 10.1007/S11060-014-1375-8  0.62
2014 Bandopadhayay P, Bergthold G, Nguyen B, Schubert S, Gholamin S, Tang Y, Bolin S, Schumacher SE, Zeid R, Masoud S, Yu F, Vue N, Gibson WJ, Paolella BR, Mitra SS, et al. BET bromodomain inhibition of MYC-amplified medulloblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 912-25. PMID 24297863 DOI: 10.1158/1078-0432.Ccr-13-2281  0.425
2014 Sengupta S, Weeraratne SD, Sun H, Phallen J, Rallapalli SK, Teider N, Kosaras B, Amani V, Pierre-Francois J, Tang Y, Nguyen B, Yu F, Schubert S, Balansay B, Mathios D, et al. α5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth. Acta Neuropathologica. 127: 593-603. PMID 24196163 DOI: 10.1007/S00401-013-1205-7  0.377
2014 Tang Y, Schubert S, Qi J, Nguyen B, Masoud S, Vue N, Balansay B, Yu F, Atwood SX, Whitson RJ, Ponnuswami A, Chen S, Gholamin S, Pamelyn WJ, Monje-Diesseroth M, et al. Abstract B6: Epigenetic regulation of Hedgehog pathway transcriptional output by BET bromodomain proteins Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-B6  0.426
2014 Bender S, Tang Y, Lindroth AM, Hovestadt V, Zapatka M, Jones DTW, Kool M, Northcott PA, Sturm D, Lichter P, Plass C, Cho Y. Abstract 3084: Epigenetic deregulation in H3.3-K27M mutant pediatric high-grade gliomas Cancer Research. 74: 3084-3084. DOI: 10.1158/1538-7445.Am2014-3084  0.351
2014 Cho Y, Tang Y, Schubert S, Willardson M, Bandopadhayay P, Bergthold G, Nguyen B, Masoud S, Vue N, Balansay B, Gholamin S, Cheshier SH, Atwood SX, Whitson RJ, Lee A, et al. EPIGENETIC TARGETING OF HEDGEHOG PATHWAY TRANSCRIPTIONAL OUTPUT Neuro-Oncology. 16: iii25-iii25. DOI: 10.1093/Neuonc/Nou208.9  0.458
2014 Classen CF, William D, Linnebacher M, Farhod A, Kedr W, Elsabe B, Fadel S, Van Gool S, De Vleeschouwer S, Koks C, Garg A, Ehrhardt M, Riva M, De Vleeschouwer S, Agostinis P, ... ... Tang Y, et al. HIGH GRADE GLIOMAS AND DIPG Neuro-Oncology. 16: i40-i59. DOI: 10.1093/Neuonc/Nou071  0.529
2013 Bender S, Tang Y, Lindroth AM, Hovestadt V, Jones DT, Kool M, Zapatka M, Northcott PA, Sturm D, Wang W, Radlwimmer B, Højfeldt JW, Truffaux N, Castel D, Schubert S, et al. Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Cancer Cell. 24: 660-72. PMID 24183680 DOI: 10.1016/J.Ccr.2013.10.006  0.543
2013 Agarwal M, Nitta R, Dovat S, Li G, Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, ... ... Tang Y, et al. CELL BIOLOGY AND SIGNALING Neuro-Oncology. 15: iii12-iii31. DOI: 10.1093/Neuonc/Not174  0.499
Show low-probability matches.